Mouse Anti-CLEC11A Recombinant Antibody (CBYY-C3048) (V2LY-1206-LY78)

Yin, C., Zhang, J., Guan, W., Dou, L., Liu, Y., Shen, M., ... & Li, Y. (2021). High expression of CLEC11A predicts favorable prognosis in acute myeloid leukemia. Frontiers in Oncology, 11, 22.

Wang, M., Guo, J., Zhang, L., Kuek, V., Xu, J., & Zou, J. (2020). Molecular structure, expression, and functional role of Clec11a in skeletal biology and cancers. Journal of cellular physiology, 235(10), 6357-6365.

Hu, Y., Zhang, Y., Ni, C. Y., Chen, C. Y., Rao, S. S., Yin, H., ... & Xie, H. (2020). Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. Theranostics, 10(5), 2293.

Chaboya, C. (2019). Elucidating the signaling pathways for the c-type lectin clec11a in human mesenchymal stromal cells.

Shi, R., Hu, J., Li, W., Wang, Z., Pan, Y., Bai, M., ... & Zhao, S. (2019). Protective effects of Clec11a in islets against lipotoxicity via modulation of proliferation and lipid metabolism in mice. Experimental cell research, 384(1), 111613.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols